S100A8 and acute lymphoblastic leukemia: Interestingly, in agreement with the linear modeling approach that identified the upregulation of S100A8 in relapsed ALL (2/3 microarray datasets, Fig. 1), the meta-analysis also detected this candidate probe as the most significantly upregulated target (Table 1).